Delivery Order SPE2DR25D3401-SPE2DR26FL1BF
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $4,436.76 to AmerisourceBergen Drug Corp for the supply of Vivitrol 380 mg vials with diluents. This firm fixed-price, non-set-aside contract was awarded on January 9, 2026, with an ultimate completion date of January 12, 2026. The pharmaceutical product will be delivered to the Conshohocken, Pennsylvania location. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a delivery order valued at $11,451.68 to AmerisourceBergen Drug Corp for the supply of Vivitrol 380 mg vial-diluents. The contract is firm fixed price, non-competitive set-aside, with an ultimate completion date of July 29, 2025, just one day following the award date of July 28, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement,...
- The Defense Logistics Agency awarded a delivery order valued at $4,436.76 to AmerisourceBergen Drug Corp for the supply of Vivitrol 380 mg vial-diluents. This firm fixed-price, competitively awarded contract was issued on January 9, 2026, with an ultimate completion date of January 12, 2026. The work will be performed at AmerisourceBergen Drug Corp's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's existing Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $4,436.76 to AmerisourceBergen Drug Corp for the supply of Vivitrol 380 mg vials and diluents. This non-competitive, firm fixed price delivery order was awarded on January 5, 2026, with an ultimate completion date of January 6, 2026. The product will be delivered to the vendor's location in Conshohocken, Pennsylvania. This award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $5,730.90 on October 27, 2025, for the supply of Vivitrol 380 mg vial-diluents. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of October 28, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,379.06 on January 9, 2026, for the supply of Vivitrol 380 mg vial-diluents. The contract, which represents a firm fixed-price transaction with an ultimate completion date of January 12, 2026, was competitively awarded with no set-aside designation. This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger...
- The Defense Logistics Agency awarded a delivery order valued at $3,327.57 to AmerisourceBergen Drug Corp for the supply of Vivitrol 380 mg vials and diluents. This firm fixed-price contract, awarded on January 8, 2026, with a completion date of January 9, 2026, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The contract was competitively awarded with no set-aside designation and will be performed at the awardee's facility in...
- The Defense Logistics Agency awarded a $2,218.38 firm fixed-price delivery order to Amerisourcebergen Drug Corp (parent company Cencora, Inc.) on January 12, 2026, for Vivitrol 380 mg vials with diluents. The contract, which is not set-aside, is scheduled for ultimate completion on January 13, 2026, with performance taking place at the vendor's facility in Conshohocken, Pennsylvania. This delivery order represents a task order under a larger Indefinite Delivery Contract vehicle with the DLA...
- The Defense Logistics Agency has awarded a delivery order valued at $40,167.61 to AmerisourceBergen Drug Corp for the supply of Vivitrol 380 mg vials and diluents. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of December 10, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The delivery order represents a single transaction under a larger contract vehicle supporting the federal...
- The Defense Logistics Agency awarded a delivery order valued at $4,357.27 to AmerisourceBergen Drug Corp for the supply of Vivitrol 380 mg vial-diluents, with an ultimate completion date of September 17, 2025. This is a firm fixed price contract with no set-aside designation, reflecting competitive procurement practices. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is executed under...
- SPE2DR25D3401Indefinite Delivery Contract
- SPE2DR25D3401-SPE2DR26FL1BFDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,218.38 to Amerisourcebergen Drug Corp for the supply of Vivitrol 380 mg vial-diluents, with performance in Conshohocken, Pennsylvania and a completion date of January 15, 2026. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The award was made on January 14, 2026, and represents a task order issued under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. Amerisourcebergen Drug Corp, a subsidiary of parent company Cencora, Inc. (doing business as Amerisourcebergen), is a major pharmaceutical distributor serving critical federal medical procurement needs. The company demonstrates extensive capability in supplying brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to the Defense Logistics Agency, Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. Vivitrol, an opioid antagonist medication used primarily in medication-assisted treatment programs, represents one of the specialized pharmaceutical products delivered through the company's federal contract portfolio.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 1/13/26 |